Skip to main content
SpringerLink
Log in

Therapeutic Insights

  • Chapter
  • First Online:
Essential Medical Facts Every Clinician Should Know

  • 1323 Accesses

Abstract

To introduce this chapter, I selected a case in which we actually helped the patient. Despite all the perils of twenty-first century therapy, we sometimes get things right. Here is one such story.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bloomfield AL. Quoted in: Strauss MB. Familiar medical quotations. Boston: Little, Brown; 1968. Page 637.

    Google Scholar 

  2. Albert NM, Yancy CW, Liang L, et al. Use of aldosterone antagonists in heart failure. JAMA. 2009;302(15):1658–1685.

    Article  PubMed  CAS  Google Scholar 

References

  1. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297.

    Article  PubMed  Google Scholar 

  2. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including the NICE-SUGAR study data. CMAJ. 2009;180(8):821–827.

    Article  PubMed  Google Scholar 

Reference

  1. Gamble JM, Simpson SH, Eurich DT, et al. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab. 2010;12(1):47–53.

    Article  PubMed  CAS  Google Scholar 

References

  1. Tzoulaki I, Molokhia M, Curcin V, et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetic drugs: retrospective cohort study using UK general practice research base. BMJ. 2009;339:b4731.

    Article  PubMed  Google Scholar 

  2. Howlett HCS, Bailey CJ. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf. 1999;20(6):489–503.

    Article  PubMed  CAS  Google Scholar 

  3. Capelli C, Rotondi M, Pirola I, et al. TSH-lowering effect of metformin in type 2 diabetic patients: difference between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care. 2009;32(9):1589–1590.

    Article  Google Scholar 

  4. FDA Alert: Exenatide (marketed as Byetta). Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111085.htm. Accessed August 26, 2009.

  5. Home PD, Pocock SJ, Beck-Nielsen H, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicenter, randomized, open-label trial. Lancet. 2009;373(9681):2125–2135.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Wu RR, Zhao JP, Jin H et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008;299:185–193.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Teeuw WJ, Gerdes VI, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):421–427.

    Article  PubMed  Google Scholar 

References

  1. Cipriani A, La Ferla T, Furukawa TA, et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010;Jan 20(1):CD006117.

    Google Scholar 

  2. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity. JAMA. 2010;303(1):47–53.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2009;7(12):1314–1321.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med. 2009;163(10):949–954.

    Article  PubMed  Google Scholar 

Reference

  1. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med. 2009;169(22):2128–2139.

    Article  PubMed  Google Scholar 

References

  1. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to U.S. Food and Drug Administration. BMJ. 2009;339:b3066.

    Article  Google Scholar 

  2. Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults. Arch Gen Psychiatry. 2006;63(8):865–872.

    Article  PubMed  Google Scholar 

References

  1. Shores MM, Kivlahan DR, Sadak TI, Li EJ, Matsumoto AM. A randomized, double-blind, placebo-controlled study of testosterone treatment of hypogonadal older men with subthreshold depression (dysthymia or minor depression). Clin Psychiatry. 2009;70(7):1009–1016.

    Article  CAS  Google Scholar 

  2. Bhasin S, Cunningham GR. Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006; 91(6):1995–2010.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Lipscombe LL, Levesque L, Gruneir A, et al. Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med. 2009;169(14):1282–1289.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765–1773.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomized placebo-controlled trial. Lancet Neurol. 2009;8(2):151–157.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Amminger GP, Schafer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67(2):146–154.

    Article  PubMed  CAS  Google Scholar 

References

  1. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiologic studies. BMJ. 2009;338:b1665.

    Article  PubMed  CAS  Google Scholar 

  2. Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. BMJ. 2008;336(7653):1121–1123.

    Article  PubMed  CAS  Google Scholar 

References

  1. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database Syst Rev. 2009;July 8(3):CD001841.

    Google Scholar 

  2. Wiysonge CS, Bradley H, Mayosi BM, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2007;Jan 24(1):CD002003.

    Google Scholar 

  3. Kahn N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ. 2006;174(12):1737–1742.

    Article  Google Scholar 

  4. Lindsay JA. Medical axioms, aphorisms and clinical memoranda. London: H.K. Lewis Co.; 1923. Page 86.

    Google Scholar 

Reference

  1. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290–300.

    Article  PubMed  Google Scholar 

References

  1. Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev. 2009;Jul 8(3):CD004349.

    Google Scholar 

  2. Verdecchia P, Staessen JA, Anteli F, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomized trial. Lancet. 2009;374(9689):525–533.

    Article  PubMed  Google Scholar 

References

  1. Kessler C, Youdeh Y. Evaluation and treatment of severe asymptomatic hypertension. Am Fam Physician. 2010;81(4):470–476.

    PubMed  Google Scholar 

  2. Decker WW, Godwin SA, Hess EP, Lenamond CC, Jagoda AS, for the American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Asymptomatic Hypertension in the ED. Clinical policy: critical issues in the evaluation and management of adult patients with asymptomatic hypertension in the emergency department. Ann Emerg Med. 2006;47(3):237–249.

    Article  PubMed  Google Scholar 

Reference

  1. Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology. 2010;112(1):25–33.

    Article  PubMed  Google Scholar 

Reference

  1. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358:2667–2777.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Van Gelder I, Groenveld HF, Crijns HJG, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362(15):1363–1373.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007;38(2):423–430.

    Article  PubMed  CAS  Google Scholar 

References

  1. Lipinski MJ, Cauthren CA, Biondi-Zoccai GG, et al. Meta-analysis of randomized ­controlled trials versus placebo in patients with heart failure. Am J Cardiol. 2009;104(12):1708–1716.

    Article  PubMed  CAS  Google Scholar 

  2. Bodmer M, Brauchli YB, Krähenbühl S, Jick SS, Meier CR. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA. 2009;302(18):2001–2007.

    Article  PubMed  CAS  Google Scholar 

  3. Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2004;117(8):596–606.

    Article  PubMed  CAS  Google Scholar 

  4. Shannon J, Tewoderos S, Garzotto M, et al. Statins and prostate cancer risk: a case-control study. Am J Epidemiol. 2005;162(4):318–325.

    Article  PubMed  Google Scholar 

  5. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39(5):967–976.

    Article  PubMed  Google Scholar 

  6. Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361(10):980–989.

    Article  PubMed  CAS  Google Scholar 

  7. Brookes ZL, McGown CC, Reilly CS. Statins for all: the new premed? Br J Anaesth. 2009;103(1):99–107.

    Article  PubMed  CAS  Google Scholar 

References

  1. de Denus S, Spinler SA, Miller K, Peterson AM. Statins and liver toxicity: a meta-analysis. Pharmacotherapy. 2004;24(5):584–591.

    Article  PubMed  CAS  Google Scholar 

  2. Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver en­zymes are not at higher risk for statin hepatotoxicity. Gastroenterology. 2004;126(5):1287–1292.

    Article  PubMed  CAS  Google Scholar 

  3. Schreiber DH, Anderson TR. Statin-induced rhabdomyolysis. J Emerg Med. 2006;31(2):177–180.

    Article  PubMed  Google Scholar 

  4. Lenz TL. Are physically active individuals taking statins at increased risk for myopathy? Am J Lifestyle Med. 2009;3(4):287–289.

    Article  Google Scholar 

  5. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy. 2003;23(7):871–880.

    Article  PubMed  Google Scholar 

  6. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010;375(9716):735–742.

    Article  PubMed  Google Scholar 

  7. Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for ­dyslipidemia in statin-intolerant patients. Ann Intern Med. 2009;150(12):830–839.

    PubMed  Google Scholar 

References

  1. Physicians’ Desk Reference, 2009, page 1476.

    Google Scholar 

  2. Kaniecki RG. Basilar-type migraine. Curr Pain Headache Rep 2009; 13(3):217–220.

    Article  PubMed  Google Scholar 

  3. Artto V, Nissilä M, Wessman M, et al. Treatment of hemiplegic migraine with triptans. Eur J Neurol 2007; 14(9):1053–1056.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. 2009;302(22):2451–2457.

    Article  PubMed  CAS  Google Scholar 

References

  1. Pumariega AJ, Nelson R, Rotenberg L. Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectr 2008;13(6):511–514.

    PubMed  Google Scholar 

  2. Pharmacology Watch. December, 2008. Page 2.

    Google Scholar 

  3. Moore TJ, Cohen MR, Furberg CD. Strong safety signal seen for new varenicline risks. The Institute for Safe Medication Practices. Published May 21, 2008. Available at: http://www.ismp.org/docs/vareniclineStudy.asp/ Accessed March 12, 2010.

  4. McIntyre RS. Varenicline and suicidality: a new era in medication safety surveillance. Expert Opin Drug Saf. 2008;7(5):511–514.

    Article  PubMed  CAS  Google Scholar 

  5. Patterson F, Jepson C, Strasser A, et al. Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry. 2009;65(2):144–149.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360(16):1597–1605.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Li Q, Chen, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2009;April 15(2):CD006866.

    Google Scholar 

References

  1. de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009;302(9):1003–1004.

    Article  Google Scholar 

  2. Quant EC, Jeste SS, Muni RH, et al. The benefits of steroids versus steroids plus antivirals for treatment of Bell palsy: a meta-analysis. BMJ. 2009;339:b3354.

    Article  PubMed  Google Scholar 

  3. Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell palsy. N Engl J Med. 2007;357(16):1598–1607.

    Article  PubMed  CAS  Google Scholar 

References

  1. Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA. 2007;298(21):2487–2496.

    Article  PubMed  CAS  Google Scholar 

  2. Meador CK. A little book of doctors’ rules. Philadelphia: Hanley & Belfus; 1999. Rule ­number 25.

    Google Scholar 

Reference

  1. Korb K, Scherer M, Chenot JF. Steroids as adjuvant therapy for acute pharyngitis in ambulatory patients: a systematic review. Ann Fam Med. 2010;8(1):58–63.

    Article  PubMed  Google Scholar 

Reference

  1. Salpeter SR, Wall AJ, Buckley NS. Long-acting beta-agonists with and without corticosteroids and catastrophic asthma events. Am J Med. 2010;123(4):322–328.

    Article  PubMed  CAS  Google Scholar 

References

  1. Owen RT. A novel treatment for premature ejaculation. Drugs Today. 2009;45(9):669–678.

    Article  PubMed  CAS  Google Scholar 

  2. Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomized controlled trials. Lancet. 2006;368(9539):929–937.

    Article  PubMed  CAS  Google Scholar 

References

  1. McVary KT, Monnig W, Camps J Jr, Young J, Tseng L, von den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hypertrophy: a randomized, double-blind trial. J Urol. 2007;177(3):1071–1077.

    Article  PubMed  CAS  Google Scholar 

  2. Mouli S, McVary KT. PDE5 inhibitors for LUTS. Prostate Cancer Prostatic Dis. 2009;12(4):316–324.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Ghofrani HA, Reichenberger F, Kohstall MG, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med. 2004;141(3):169–177.

    PubMed  CAS  Google Scholar 

Reference

  1. Winter ME, Tozer TN. Phenytoin. In: Burton ME, Shaw LM, Schentag JJ, Evans WE, eds. Applied pharmacokinetics and pharmacodynamics: Principles of therapeutic drug monitoring. Ed 4. Philadelphia: Lippincott, Williams & Wilkins; 2005. Pages 464–490.

    Google Scholar 

References

  1. –2010 NCAA Banned Drugs. Available at: http://www.ncaa.org/wps/wcm/connect/53e6f4804e0b8a129949f91ad6fc8b25/2009–10+Banned+Drug+Classes.pdf?MOD=AJPERES&CACHEID=53e6f4804e0b8a129949f91ad6fc8b25. Accessed March 15, 2010.

  2. The 2010 Prohibited List. World Anti-Doping Agency. Available at: http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/ Accessed March 15, 2010.

Reference

  1. Lutters M, Vogt-Ferrier NB. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev. 2008;Jul 16;(3);CD1535.

    Google Scholar 

References

  1. Schuetz P, Chrit-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs ­standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP ­randomized controlled trial. JAMA. 2009;302(10):1059–1066.

    Article  PubMed  CAS  Google Scholar 

  2. Can procalcitonin testing reduce antibiotic prescribing for respiratory infections? Age and Ageing. Available at: http://ageing.oxfordjournals.org/cgi/content/full/35/6/625. Accessed March 15, 2010.

Reference

  1. Cals JW, Schot MJ, de Jong SA, Dinant GJ, Hopstaken RM. Point of care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med. 2010;8(2):124–133.

    Article  PubMed  Google Scholar 

References

  1. Primaquine. Centers for Disease Prevention and Control. The Pre-travel consultation. Available at: http://wwwnc.cdc.travel/yellowbook/2010/chapter-2/malaria.aspx. Accessed March 15, 2010.

  2. Mason PJ, Bautista JM, Gilsanz F, et al. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007;21(5):267–283.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Ipp M, Parkin PC, Lear N, et al. Order of vaccine injection and infant pain response. Arch Pediatr Adolesc Med. 2009;163(5):469–472.

    Article  PubMed  Google Scholar 

References

  1. Roslund G, Hepps TS, McQuillen KK, et al. The role of oral ondansetron in children with vomiting as a result of acute gastritis/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial. Ann Emerg Med. 2008;52(1):22–29.

    Article  PubMed  Google Scholar 

  2. DeCamp LR, Byerley JS, Doshi N, Steiner MJ. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2008;162(9):858–865.

    Article  PubMed  Google Scholar 

  3. Malek MA, Curns AT, Holman RC, et al. Diarrhea-and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117(5):1887–1892.

    Article  PubMed  Google Scholar 

References

  1. Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. 2009;24(6):1095–1102.

    Article  PubMed  CAS  Google Scholar 

  2. Black DM, Kelly MP, Genant HK, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362(19):1761–1771.

    Article  PubMed  CAS  Google Scholar 

  3. Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144(10):753–761.

    PubMed  CAS  Google Scholar 

Reference

  1. Lautenschlater NT, Cox KL, Flicker L, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease. JAMA. 2008;300(9):1027–1037.

    Article  Google Scholar 

Reference

  1. Prakash S, Shah ND. Chronic tension-type headache with vitamin D deficiency: casual or causal association? Headache. 2009;49(8):1214–1222.

    Article  PubMed  Google Scholar 

Reference

  1. Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Med. 2009;22:9–16.

    Article  PubMed  Google Scholar 

Reference

  1. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360(9326):23–33. #####

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine School of Medicine, Oregon Health & Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon, 97239, USA

    Robert B. Taylor

Authors
  1. Robert B. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert B. Taylor .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Taylor, R.B. (2011). Therapeutic Insights. In: Essential Medical Facts Every Clinician Should Know. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7874-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7874-5_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-7873-8

  • Online ISBN: 978-1-4419-7874-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation